MOONLAKE IMMUNOTHERAPEUTICS Current Assets
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) had Current Assets of $570.04 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-10
- 2026-06-30: Assets, Current $570.04M.
- 2026-03-31: Assets, Current $396.64M.
- 2025-12-31: Assets, Current $421.69M.
- 2025-09-30: Assets, Current $411.21M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $570.04M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $396.64M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $421.69M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $411.21M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $455.48M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $506.26M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $474.29M 10-K · filed 2026-02-25 | $474.29M 10-K · filed 2025-02-26 |
| 2024-09-30 | $512.32M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $536.88M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $553.59M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $514.17M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $500.01M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $506.37M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $66.50M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $76.51M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $88.54M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $98.38M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $116.16M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $9.64M 10-K · filed 2023-03-20 | $793.71K 10-K · filed 2022-02-17 |
| 2021-09-30 | $1.21M 10-Q/A · filed 2021-12-14 | |
| 2021-06-30 | $1.33M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.46M 10-Q · filed 2021-05-21 | |
| 2020-12-31 | $1.62M 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |